162 related articles for article (PubMed ID: 11562959)
1. Bicyclic furo pyrimidine nucleosides with aryloxyphenyl and halophenyl substituted side chains as potent and selective varicella-zoster virus inhibitors.
Blewett S; McGuigan C; Barucki H; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1063-6. PubMed ID: 11562959
[TBL] [Abstract][Full Text] [Related]
2. Novel aryl substituted bicyclic furo nucleosides as extremely potent and selective anti-VZV agents.
McGuigan C; Barucki H; Carangio A; Blewett S; Srinivasan S; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):287-96. PubMed ID: 11563040
[No Abstract] [Full Text] [Related]
3. Bicyclic anti-VZV nucleosides: thieno analogues bearing an alkylphenyl side chain have reduced antiviral activity.
Angell A; McGuigan C; Garcia Sevillano L; Snoeck R; Andrei G; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2004 May; 14(10):2397-9. PubMed ID: 15109620
[TBL] [Abstract][Full Text] [Related]
4. Halophenyl furanopyrimidines as potent and selective anti-VZV agents.
McGuigan C; Jukes A; Blewett S; Barucki H; Erichsen JT; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2003 May; 14(3):165-70. PubMed ID: 14521333
[TBL] [Abstract][Full Text] [Related]
5. Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain.
McGuigan C; Barucki H; Carangio A; Blewett S; Andrei G; Snoeck R; De Clercq E; Balzarini J; Erichsen JT
J Med Chem; 2000 Dec; 43(26):4993-7. PubMed ID: 11150169
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro evaluation of novel anti-varicella-zoster virus (VZV) nucleosides.
Carangio A; McGuigan C; Cahard D; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):653-6. PubMed ID: 11563084
[TBL] [Abstract][Full Text] [Related]
7. Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): effect of terminal unsaturation in the side-chain.
Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):763-6. PubMed ID: 11563111
[TBL] [Abstract][Full Text] [Related]
8. Bicyclic nucleoside inhibitors of varicella-zoster virus: 5'-chloro and 3'-chloro derivatives.
Luoni G; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):931-3. PubMed ID: 14565314
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of unusual bicyclic nucleosides bearing an unsaturated side-chain, as potential inhibitors of varicella-zoster virus (VZV).
Bidet O; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):817-9. PubMed ID: 14565286
[No Abstract] [Full Text] [Related]
10. Bicyclic nucleoside inhibitors of Varicella-Zoster virus: the effect of branching in the p-alkylphenyl side chain.
Luoni G; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2005 Aug; 15(16):3791-6. PubMed ID: 15993062
[TBL] [Abstract][Full Text] [Related]
11. Bicyclic nucleoside inhibitors of varicella-zoster virus: effect of terminal aryl substitution in the side-chain.
Carangio A; Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2002 Sep; 13(5):263-71. PubMed ID: 12630674
[TBL] [Abstract][Full Text] [Related]
12. Alkenyl substituted bicyclic nucleoside analogues retain nanomolar potency against Varicella Zoster Virus.
McGuigan C; Bidet O; Derudas M; Andrei G; Snoeck R; Balzarini J
Bioorg Med Chem; 2009 Apr; 17(8):3025-7. PubMed ID: 19328697
[TBL] [Abstract][Full Text] [Related]
13. Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of terminal unsaturation in the side chain.
Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2001 Feb; 11(3):391-3. PubMed ID: 11212118
[TBL] [Abstract][Full Text] [Related]
14. Furano pyrimidines as novel potent and selective anti-VZV agents.
McGuigan C; Brancale A; Barucki H; Srinivasan S; Jones G; Pathirana R; Carangio A; Blewett S; Luoni G; Bidet O; Jukes A; Jarvis C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2001 Mar; 12(2):77-89. PubMed ID: 11527045
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines.
Migliore MD; Zonta N; McGuigan C; Henson G; Andrei G; Snoeck R; Balzarini J
J Med Chem; 2007 Dec; 50(26):6485-92. PubMed ID: 18052321
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-varicella-zoster virus activity of some novel bicyclic nucleoside inhibitors: effect of enhanced aqueous solubility.
Brancale A; Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2000 Nov; 11(6):383-93. PubMed ID: 11227996
[TBL] [Abstract][Full Text] [Related]
17. Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d]pyrimidine nucleoside analogues.
De Clercq E
Med Res Rev; 2003 May; 23(3):253-74. PubMed ID: 12647310
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.
Balzarini J; McGuigan C
Biochim Biophys Acta; 2002 Jul; 1587(2-3):287-95. PubMed ID: 12084470
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiviral evaluation of 6-(alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one nucleosides and analogues with ethynyl, ethenyl, and ethyl spacers at C6 of the furopyrimidine core.
Robins MJ; Nowak I; Rajwanshi VK; Miranda K; Cannon JF; Peterson MA; Andrei G; Snoeck R; De Clercq E; Balzarini J
J Med Chem; 2007 Aug; 50(16):3897-905. PubMed ID: 17622128
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 6-(alkyn-1-yl)furo[2,3-d]pyrimidin-2(3H)-one base and nucleoside derivatives.
Robins MJ; Miranda K; Rajwanshi VK; Peterson MA; Andrei G; Snoeck R; De Clercq E; Balzarini J
J Med Chem; 2006 Jan; 49(1):391-8. PubMed ID: 16392824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
